RYOIX Mutual Fund (Rydex Biotechnology Fund Investor Class) is managed by Rydex Funds with $102.4M in net assets. RYOIX expense ratio is 1.39%, holding 75 positions across sectors including Health Care, Unknown, Other. Inception date: 1998-04-01.

RYOIX performance shows a YTD return of 18.92%. The 1-year return is 76.21% and the 5-year return is 10.88%. RYOIX dividend yield stands at 10.53%, paid annually.

RYOIX top holdings include Abbvie Inc Health Care (7.4%), Amgen Inc. Com (5.2%), Gilead Sciences Inc (5.0%), Vertex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). View all RYOIX holdings, sector breakdown, or dividend history.

RYOIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYOIX alternatives are available via the screener, along with tax-loss harvesting opportunities.